Corrigendum to “Thalidomide ameliorate graft chronic rejection in an allogenic kidney transplant model” [Int. Immunopharmacol. 71 (2019) 32–39] (International Immunopharmacology (2019) 71 (32–39), (S1567576918313596), (10.1016/j.intimp.2018.12.035))

doi:10.1016/j.intimp.2022.108584

科研成果详情

名称	Corrigendum to “Thalidomide ameliorate graft chronic rejection in an allogenic kidney transplant model” [Int. Immunopharmacol. 71 (2019) 32–39] (International Immunopharmacology (2019) 71 (32–39), (S1567576918313596), (10.1016/j.intimp.2018.12.035))
作者	Zhang, Yan 1,2; Yang, Yu1,3; Li, Xianduo 1; Chen, Dongdong 1; Tang, Guanbao 1; Men, Tongyi 1
发表期刊	International Immunopharmacology;
语种	英语
原始文献类型	Erratum
摘要	The authors regret that the manuscript entitled “Thalidomide ameliorate graft chronic rejection in an allogenic kidney transplant model”, which was published online as International Immunopharmacology. 2019, 6 (71): 32–39 contained the following errors. The β-actin in Fig. 4 d incorrectly used a figure from a previous study. Further, Fig. 1(a) G was misapplied as it was Fig. 6 in my doctoral degree thesis. We have carefully checked the original data and found that when we copied the selected pictures to the first author's computer, we used an incorrect overlay, which led to the release of the figure as duplicate images. I did not carefully check the figures and did not note the duplication. This resulted in this unacceptable mistake, for which I take responsibility. Recently, we carefully checked the original data and guarantee the authenticity of our amended research data. I hereby declare that the figures in Fig. 1 of this corrigendum are now correct. In our published article, Fig. 1(a) G was misapplied as it was Fig. 6 in my doctoral degree thesis, as shown in the red box in the figure below. [Figure presented] In the new Fig. 1, we corrected Fig. 1(a) G, as shown in the red box in the figure below. [Figure presented] The final corrected image is as follows [Figure presented] In our published article, the β-actin in Fig. 4 d incorrectly used a band from previous study, as shown in the red box in the figure below. [Figure presented] In the new Fig. 4, we corrected figure (b), (c) and (d), as shown in the red box in the figure below. [Figure presented] The final corrected image is as follows [Figure presented] The authors would like to apologise for any inconvenience caused.
出版者	ELSEVIER
ISSN	1567-5769
EISSN	1878-1705
卷号	107
DOI	10.1016/j.intimp.2022.108584
页数	6
WOS类目	Immunology ; Pharmacology & Pharmacy
WOS研究方向	Immunology ; Pharmacology & Pharmacy
WOS记录号	WOS:000802905300001
收录类别	SCOPUS ; SCIE
发布日期	2022-06-01
URL	查看原文
PubMed ID	35484056
通讯作者地址	[Men, Tongyi]Shandong Univ, Qianfoshan Hosp, Dept Urol, Jingshi Rd, Jinan 16766, Shandong, Peoples R China.
Scopus学科分类	Immunology and Allergy;Immunology;Pharmacology
SCOPUSEID	SCOPUS_ID:85129652017
TOP期刊	TOP期刊
引用统计
文献类型	其他
条目标识符	https://kms.wmu.edu.cn/handle/3ETUA0LF/184755
专题	第一临床医学院（信息与工程学院）、附属第一医院
通讯作者	Men, Tongyi
作者单位	1.Shandong Univ, Qianfoshan Hosp, Dept Urol, Jingshi Rd, Jinan 16766, Shandong, Peoples R China; 2.Wenzhou Med Univ, Affiliate Hosp 1, Transplantat Ctr, Wenzhou, Peoples R China; 3.Wenzhou Med Univ, Affiliate Hosp 1, Dept Urol, Wenzhou, Peoples R China
第一作者单位	第一临床医学院（信息与工程学院）、附属第一医院
推荐引用方式 GB/T 7714	Zhang, Yan,Yang, Yu,Li, Xianduo,et al. Corrigendum to “Thalidomide ameliorate graft chronic rejection in an allogenic kidney transplant model” [Int. Immunopharmacol. 71 (2019) 32–39] (International Immunopharmacology (2019) 71 (32–39), (S1567576918313596), (10.1016/j.intimp.2018.12.035)). 2022.